LATEST ALERTS
The CBD regulatory tracker offers a deep analysis of the regulations and proposals in over 50 countries, for nine major regulatory areas: hemp cultivation, processing, flower, extracts, food, cosmetics, vaping, pet food and import/export
Changes at the UK Food Standards Agency (FSA) have helped to move the process of CBD as a novel ingestible ingredient along to the point where a successful full approval can be expected soon
A product from a CBD company has again been called out by the UK Advertising Standards Authority (ASA) for allegedly making unsubstantiated health and nutrition claims, but this time the claims were not about CBD
Join host Barnaby Page as he speaks with Richard Young about the role of toxicology in vape product safety
The cannabinoid sector is unlikely to find an ally in new US surgeon general nominee Casey Means, but she could help further progress towards a viable commercial psychedelics market in the country
Italy’s Regional Administrative Court (TAR) has dismissed an appeal challenging the Ministry of Health’s decree to classify oral CBD products as narcotics
A not-so-new tech enabling growers to sort seeds before planting could be a major cost cutter in an industry built on fine margins and continually having to compete with cheaper, untaxed black market products
The United Nations Commission on Narcotic Drugs voted on 12th March to classify HHC as a banned substance, with an aim of restricting and controlling the use of the cannabinoid at an international level
Knowledge about cannabinoids and other cannabis compounds continues to inch forward, but though most recent major reported studies have been positive, that has not universally been the case
Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond
Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine regulation.
Cannabis companies have been pushing the envelope of acceptable marketing and business practices by insinuating unproven benefits for their products while also looking to create the strongest goods possible
As of 1st January 2025, eligible patients in Luxembourg will no longer be able to receive prescriptions for dried cannabis flower with a high THC content
Join the Tamarind Intelligence leadership team for a compelling round-table discussion with four top industry experts. They’ll reflect on the major moments of 2024 in the reduced-risk nicotine world and share their insights for 2025.
Cannabis may help sleep, according to Australian researchers who found evidence of the hypnotic properties of cannabinol (CBN) and say their study is the first to use objective measures to prove CBN increases sleep
Rupert Wilson, managing director at Strategic Business Consulting and former Rothmans International tobacco expert, sits down with Tamarind Intelligence’s Tim Phillips to examine the influence of novel nicotine products on the performance and strategic direction of public tobacco firms.
Canada-based vaping hardware maker Greentank has launched a partnership with Dubai-headquartered group AIR Global, as the shisha market specialist aims to enter the global wellness sector
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
Brazilian pharmaceutical company Ease Labs officially announced the acquisition this month of Plena, a cannabis cultivation and extraction company based in Colombia
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
